Zobrazeno 1 - 10
of 76
pro vyhledávání: '"Anneke J van Vuuren"'
Autor:
Miriam P van der Meulen, Esther Toes-Zoutendijk, Manon C W Spaander, Evelien Dekker, Johannes M G Bonfrer, Anneke J van Vuuren, Ernst J Kuipers, Folkert J van Kemenade, M F van Velthuysen, Maarten G J Thomeer, Harriët van Veldhuizen, Harry J de Koning, Iris Lansdorp-Vogelaar, Monique E van Leerdam
Publikováno v:
PLoS ONE, Vol 17, Iss 2, p e0264067 (2022)
BackgroundCRC mortality rates are higher for individuals with a lower socioeconomic status (SES). Screening could influence health inequalities. We therefore aimed to investigate SES differences in participation and diagnostic yield of FIT screening.
Externí odkaz:
https://doaj.org/article/e7fe54056bab45988b6bf72476626bd2
Autor:
Emilie C. H. Breekveldt, Esther Toes-Zoutendijk, Lucie de Jonge, Manon C. W. Spaander, Evelien Dekker, Folkert J. van Kemenade, Anneke J. van Vuuren, Christian R. B. Ramakers, Iris D. Nagtegaal, Monique E. van Leerdam, Iris Lansdorp-Vogelaar
Publikováno v:
BMC Gastroenterology, Vol 23, Iss 1, Pp 1-10 (2023)
Abstract Background In 2014, the national population-based colorectal cancer (CRC) screening program was implemented in the Netherlands. Biennial fecal immunochemical testing (FIT) for hemoglobin (Hb) is used at a cut-off of 47 µg Hb per gram feces.
Externí odkaz:
https://doaj.org/article/71f5004844c04b1dbb3dcc68d0adf6e4
Autor:
David E. F. W. M. van Toledo, Emilie C. H. Breekveldt, Joep E. G. IJspeert, Anneke J. van Vuuren, Folkert J. van Kemenade, Christian Ramakers, Iris D. Nagtegaal, Monique E. van Leerdam, Manon C. W. Spaander, Iris Lansdorp-Vogelaar, Esther Toes-Zoutendijk, Evelien Dekker
Publikováno v:
Endoscopy. GEORG THIEME VERLAG KG
Endoscopy
Endoscopy. Georg Thieme Verlag
Endoscopy, 55(6), 526-534. Georg Thieme Verlag
Endoscopy, 55, 526-534
Endoscopy, 55, 6, pp. 526-534
Endoscopy
Endoscopy. Georg Thieme Verlag
Endoscopy, 55(6), 526-534. Georg Thieme Verlag
Endoscopy, 55, 526-534
Endoscopy, 55, 6, pp. 526-534
Contains fulltext : 293223.pdf (Publisher’s version ) (Closed access) BACKGROUND : Advanced serrated polyps (ASPs) have a comparable risk to advanced adenomas for progression to colorectal cancer (CRC). The yield of most CRC screening programs, how
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::47fcc918aac47ff8440926f11cf53223
https://doi.org/10.1055/a-1971-3488
https://doi.org/10.1055/a-1971-3488
Autor:
Esther Toes-Zoutendijk, Lucie de Jonge, Carola Adriana van Iersel, Manon C W Spaander, Anneke J van Vuuren, Folkert van Kemenade, Christian R Ramakers, Evelien Dekker, Iris D Nagetaal, Monique E van Leerdam, Iris Lansdorp-Vogelaar
Publikováno v:
Gut, 72, 1319-1325
Gut, 72, 7, pp. 1319-1325
Gut. BMJ Publishing Group
Gut, 72, 7, pp. 1319-1325
Gut. BMJ Publishing Group
ObjectiveTo assess the impact of delayed invitation on screen-detected and interval colorectal cancers (CRC) within a faecal immunochemical testing (FIT)-based CRC screening programme.DesignAll individuals that participated in 2017 and 2018 with a ne
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::14926c14e609f26b12872d751e954fe6
http://hdl.handle.net/2066/293478
http://hdl.handle.net/2066/293478
Autor:
Emilie C. H. Breekveldt, Esther Toes‐Zoutendijk, Hilliene J. van de Schootbrugge‐Vandermeer, Lucie de Jonge, Arthur I. Kooyker, Manon C. W. Spaander, Anneke J. van Vuuren, Folkert J. van Kemenade, Christian Ramakers, Evelien Dekker, Iris D. Nagtegaal, Monique E. van Leerdam, Iris Lansdorp‐Vogelaar
Publikováno v:
International Journal of Cancer, 152(8), 1536-1546. WILEY
International Journal of Cancer, 152(8), 1536-1546. Wiley-Liss Inc.
International Journal of Cancer. Wiley-Liss Inc.
International Journal of Cancer, 152, 8, pp. 1536-1546
International Journal of Cancer, 152, 1536-1546
International Journal of Cancer, 152(8), 1536-1546. Wiley-Liss Inc.
International Journal of Cancer. Wiley-Liss Inc.
International Journal of Cancer, 152, 8, pp. 1536-1546
International Journal of Cancer, 152, 1536-1546
Contains fulltext : 291233.pdf (Publisher’s version ) (Open Access) The interval colorectal cancer (CRC) rate after negative fecal immunochemical testing (FIT) is an important quality indicator of CRC screening programs. We analyzed the outcomes of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1547e5bf74d1f84b35bf439e73929676
https://hdl.handle.net/https://repository.ubn.ru.nl/handle/2066/291233
https://hdl.handle.net/https://repository.ubn.ru.nl/handle/2066/291233
Autor:
Emilie C. H. Breekveldt, Esther Toes-Zoutendijk, Lucie de Jonge, Manon C. W. Spaander, Evelien Dekker, Folkert J. van Kemenade, Anneke J. van Vuuren, Christian R. B. Ramakers, Iris D. Nagtegaal, Monique E. van Leerdam, Iris Lansdorp-Vogelaar
Background: In 2014, the national population-based colorectal cancer (CRC) screening program was implemented in the Netherlands. Biennial fecal immunochemical testing (FIT) for hemoglobin is used at a cut-off of 47 microgram hemoglobin per gram feces
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f287b408cd329dca4836fefa794c2a31
https://doi.org/10.21203/rs.3.rs-2324885/v1
https://doi.org/10.21203/rs.3.rs-2324885/v1
Autor:
Emilie C.H. Breekveldt, Esther Toes-Zoutendijk, Manon C.W. Spaander, Hilliene J. van de Schootbrugge-Vandermeer, Anneke J. van Vuuren, Folkert J. van Kemenade, Christian R.B. Ramakers, Evelien Dekker, Iris D. Nagtegaal, Monique E. van Leerdam, Iris Lansdorp-Vogelaar
Publikováno v:
European Journal of Cancer, 178, 60-67
European Journal of Cancer, 178, 60-67. ELSEVIER SCI LTD
European Journal of Cancer, 178, 60-67. Elsevier Ltd.
European Journal of Cancer, 178, pp. 60-67
European Journal of Cancer, 178, 60-67. Elsevier Limited
European Journal of Cancer, 178, 60-67. ELSEVIER SCI LTD
European Journal of Cancer, 178, 60-67. Elsevier Ltd.
European Journal of Cancer, 178, pp. 60-67
European Journal of Cancer, 178, 60-67. Elsevier Limited
Background and aims: From 2014, the Dutch colorectal cancer (CRC) faecal immunochemical testing-based screening programme was gradually rolled out by birth cohort. We evaluated changes in advanced-stage CRC incidence by timing of invitation to furthe
Autor:
Jordan J. Feld, Janett Fischer, Anneke J van Vuuren, Mina S Farag, Bettina E. Hansen, Florian van Bömmel, D Deichsel, Peter Ferenci, Maria Pfefferkorn, Andre Boonstra, Harry L.A. Janssen, Thomas Berg, Margo J. H. van Campenhout
Publikováno v:
Clinical Infectious Diseases, 72(2), 202-211. Oxford University Press
Background Hepatitis B virus RNA (HBV-RNA) is a novel serum biomarker that correlates with transcription of intrahepatic covalently closed circular (cccDNA), which is an important target for pegylated interferon (PEG-IFN) and novel therapies for func
Autor:
Harry L.A. Janssen, Bettina E. Hansen, Andre Boonstra, Thomas Berg, Margo J. H. van Campenhout, Anneke J van Vuuren, D Deichsel, Maria Pfefferkorn, Florian van Bömmel, Janett Fischer
Publikováno v:
Journal of Viral Hepatitis, 27(6), 610-619. Wiley-Blackwell Publishing Ltd
Journal of Viral Hepatitis
Journal of Viral Hepatitis
Hepatitis B virus (HBV) RNA in serum is a novel biomarker that reflects cccDNA activity. We investigated whether HBV RNA can predict serological response to peginterferon (PEG‐IFN) treatment. Serum HBV RNA levels were retrospectively measured at we
Autor:
Emilie C. H. Breekveldt, Esther Toes-Zoutendijk, Manon C. W. Spaander, Hilliene J. van de Schootbrugge-Vandermeer, Anneke J. van Vuuren, Folkert J. van Kemenade, Christian Ramakers, E. Dekker, Iris D. Nagtegaal, M.E. van Leerdam, Iris Lansdorp-Vogelaar
Publikováno v:
SSRN Electronic Journal.